Yehya Al-Adwi
Overview
Explore the profile of Yehya Al-Adwi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al-Adwi Y, Westra J, Goor H, van Kempen L, Osman M, Gan C, et al.
J Autoimmun
. 2024 Aug;
148:103297.
PMID: 39098251
Objective: Systemic sclerosis-interstitial lung disease (SSc-ILD) is the leading cause of death in SSc, affecting around 50 % of the patients. Lung tissue of patients with early-stage SSc-ILD is characterized...
2.
Al-Adwi Y, Atzeni I, Doornbos-van der Meer B, van der Leij M, Varkevisser R, Kroesen B, et al.
EBioMedicine
. 2023 Nov;
98:104883.
PMID: 37995465
Background: Systemic sclerosis-interstitial lung disease (SSc-ILD) is the leading cause of death in patients with SSc. There is an unmet need for predictive biomarkers to identify patients with SSc at...
3.
van de Zande S, Abdulle A, Al-Adwi Y, Stel A, de Leeuw K, Brouwer E, et al.
Diagnostics (Basel)
. 2023 Jul;
13(13).
PMID: 37443554
Puffy fingers and Raynaud's phenomenon (RP) are important clinical predictors of the development of systemic sclerosis (SSc). We aim to assess the prevalence of SSc-related symptoms, explore pulmonary symptoms, and...
4.
Atzeni I, Al-Adwi Y, Doornbos-van der Meer B, Roozendaal C, Stel A, Goor H, et al.
Front Immunol
. 2023 Jul;
14:1189257.
PMID: 37409127
Introduction: Pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD) are the leading causes of death in systemic sclerosis (SSc). Until now, no prospective biomarker to predict new onset of...
5.
Al-Adwi Y, Atzeni I, Doornbos-van der Meer B, Abdulle A, van Roon A, Stel A, et al.
Antioxidants (Basel)
. 2023 Apr;
12(4).
PMID: 37107169
Raynaud's Phenomenon (RP) leading to repetitive ischemia and reperfusion (IR) stress, is the first recognizable sign of systemic sclerosis (SSc) leading to increased oxidative stress. High-mobility group box-1 (HMGB1) is...
6.
Al-Adwi Y, Westra J, Goor H, Burgess J, Denton C, Mulder D
Rheumatology (Oxford)
. 2022 Jul;
62(2):535-545.
PMID: 35861385
SSc is a multiphase autoimmune disease with a well-known triad of clinical manifestations including vasculopathy, inflammation and fibrosis. Although a plethora of drugs has been suggested as potential candidates to...
7.
Daga M, de Graaf I, Argenziano M, Barranco A, Loeck M, Al-Adwi Y, et al.
Toxicol In Vitro
. 2020 Feb;
65:104800.
PMID: 32084521
The potential mammalian hepatotoxicity of a new class of GSH-responsive cyclodextrin-based nanosponges loaded with the anticancer drug doxorubicin (Dox-GSH-NS) was investigated. Previous studies showed that these nanosponges can release medicaments...